Assert-IQ vs TruPlan
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected or intermittent heart rhythm disorders that are difficult to capture with shorter-term monitoring solutions. This tool is ideal for comprehensive arrhythmia detection over several years, enabling remote monitoring and proactive alerts for clinicians to manage patient conditions effectively.
View Assert-IQ →Choose TruPlan if…
Choose TruPlan if you require advanced, AI-enabled imaging software for precise pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. It is best suited for cardiologists and surgeons who need detailed 3D anatomical assessment, automated landing zone definition, and simulation capabilities (TEE, ICE, fluoroscopic) to optimize procedural outcomes and assess thrombus risk.
View TruPlan →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | TruPlan |
|---|---|---|
| Deployment | Subcutaneously implanted device with mobile app connectivity | Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Assert-IQAssert-IQ emphasizes patient comfort with minimally invasive insertion and a patient activator for symptom logging, coupled with remote monitoring capabilities via a secure cloud platform. TruPlan, while powerful, is a specialized imaging software with an on-premise, thick-client deployment, suggesting a more specialized user base and potentially higher IT overhead for setup and maintenance.
Clinical Value
TruPlanTruPlan offers AI-enabled comprehensive pre-procedural planning and post-procedural follow-up for complex Left Atrial Appendage Closure (LAAC) procedures, including automated LAA landing zone definition and various simulations. This directly enhances the accuracy, efficiency, and safety of a high-risk interventional procedure, potentially leading to better patient outcomes and reduced complications. Assert-IQ provides valuable long-term diagnostic and management insights for arrhythmias, but TruPlan's direct impact on procedural success for a complex intervention offers a distinct clinical advantage.
Pricing & Value
TruPlanTruPlan's pricing details indicate it 'may be accessible at no additional cost through Boston Scientific representatives' when bundled with WATCHMAN procedures. This potential for no additional cost offers a significantly higher value proposition compared to Assert-IQ's standard enterprise pricing model, which requires direct contact with Abbott Medical for institutional pricing.
Enterprise Readiness
Assert-IQAssert-IQ targets large health systems and offers a hybrid deployment model with a secure cloud-based data platform, providing greater flexibility and scalability for large enterprises. TruPlan, while FDA cleared and HIPAA compliant, relies on an on-premise, thick-client deployment, which can present more challenges for widespread enterprise deployment and maintenance.
Innovation
TruPlanTruPlan demonstrates a higher degree of specialized AI innovation by applying it to complex, multi-modal simulations and automated anatomical definitions for pre-procedural planning of Left Atrial Appendage Closure. This directly impacts the precision and safety of a high-stakes intervention, representing a more advanced and integrated application of AI for procedural guidance. Assert-IQ's advanced arrhythmia detection algorithms and long-term remote monitoring are innovative, but TruPlan's application in interventional planning is more cutting-edge.
Support & Docs
TruPlanWhile both companies offer comprehensive documentation and technical support, TruPlan benefits significantly from the 'industry leading WATCHMAN clinical and sales representatives' provided by Boston Scientific for field support. This hands-on, specialized support for a complex procedural planning tool is a strong advantage, ensuring clinicians have expert assistance directly related to their procedures. Abbott also provides extensive manuals and technical support for Assert-IQ.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | TruPlan |
|---|---|---|
| Tool Name | Assert-IQ | TruPlan |
| Primary Function | Long-term, continuous monitoring and advanced arrhythmia detection for suspected heart rhythm disorders. | AI-enabled CT imaging software for comprehensive pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures. |
| Company | Abbott Medical | Circle Cardiovascular Imaging |
| Key Capabilities | Long-term continuous cardiac monitoring (up to 6 years), advanced arrhythmia detection algorithms, remote monitoring capabilities, proactive clinician alerts. | AI-enabled Left Heart Segmentation, automated LAA Landing Zone Definition, 3D Anatomical Assessment, TEE/ICE Simulation, Measurement and Annotation Tools. |
| Target Specialties | Cardiology, Internal Medicine | Cardiology, Cardiothoracic Surgery, Radiology |
| Mobile App Availability | None | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and TruPlan.